Diffuse Diabetic Macular Edema
Conditions
Keywords
Macula, Edema
Brief summary
Diabetic macular edema is the most common cause of visual loss among patients with diabetic retinopathy. Pars plana vitrectomy has been reported to be effective for the treatment of diabetic macular edema. Previous report showed a limited improvement in visual acuity and macular thickness posterior intraoperative triamcinolone acetonide. Bevacizumab intravitreal injection has been proven be effective in the treatment of diabetic macular edema, in recent publications. The purpose of this study is to evaluate whether vitrectomy with and without intravitreal triamcinolone acetonide and bevacizumab injection affects vision outcome and macular thickness in patients with diabetic macular edema.
Interventions
DRUGTriamcinolone Acetonide and Bevacizumab
Sponsors
Asociación para Evitar la Ceguera en México
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Diffuse diabetic macular edema * Non proliferative diabetic retinopathy * No VPP previa * No previous treament with laser, Triamcinolone acetonide, and Bevacizumab
Exclusion criteria
* Proliferative diabetic retinopathy * Previous pars plana vitrectomy * Previous treatment with diabetic macular edema * Focal macular edema * Macular Ischemia
Countries
Mexico
Outcome results
None listed